CRISPR Therapeutics Balances CASGEVY Momentum With Early Pipeline Uncertainty

CRISPR Therapeutics (NasdaqGM:CRSP) reports strong commercial momentum for its gene therapy CASGEVY, with patient initiations nearly tripling year over year. The company is preparing a regulatory ...

How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

10x Genomics CRISPR Brain Atlas Collaboration And What It Means For Investors

Genomics (NasdaqGS:TXG) is collaborating with PerturbAI, NVIDIA, and the Allen Institute on what is described as the largest in vivo CRISPR brain atlas. The partnership combines 10x Genomics' single ...
PharmiWeb

Ryvu Therapeutics to Present Preclinical Data on the ONCO Prime Platform at the 2026 AACR Annual Meeting and Announces PERO Grant Agreement

Ryvu’s ONCO Prime - an integrated precision oncology discovery platform leveraging patient-driven models, engineered systems, and high-throughput CRISPR/omics analytics. ONCO Prime enables the ...
University of California, San Francisco

Scientists Create Cancer-Fighting Immune Cells Right in the Body

UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T has the potential to treat many more cancers.

A $10.2 Billion Startup Says It’s Bringing Back Dire Wolves and Dodos-Scientists Have Questions

A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using gene-editing technology, but critics argue the animals are genetically modified gray ...

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value

Caribou Biosciences offers the strongest allogeneic CAR-T data to date, with efficacy and safety. Read why I am bullish about ...

A Dallas Startup Says It ‘De-Extincted’ the Dire Wolf. Scientists Aren’t So Sure.

A Dallas-based startup says it has produced three “de-extinct” dire wolf pups using gene-editing technology — and the dodo and woolly mammoth are next. But the gap between the company’s marketing and ...
The Daily Tar Heel

UNC’s 10th Smithies Symposium welcomes Nobel Laureate Jennifer Doudna

The 10th Annual Smithies Symposium will take place on Thursday, March 26 from 3 to 4:30 p.m. (doors open at 2:30 p.m.) in the UNC Medical Biomolecular Research Building (MBRB), Room 2204, and is open ...
Phys.org

A common CRISPR platform enables comparative studies of multicellularity in social amoebae

A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a CRISPR genome editing technique that enables comparative analysis of the ...
Science Daily

Breakthrough CRISPR system could reverse antibiotic resistance crisis

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...
Forbes

Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...